Akebia Therapeutics, Inc.

Q4 2021 13F Holders

Symbol
AKBA
CUSIP
00972D105
Type
Equity
Class
COM
Num filers
134
Total reported value, excl. options
$219M
Manager Report Date Value ($000) Shares Option Type